13,14-dihydroprostaglandin e1 has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies
| Studies (13,14-dihydroprostaglandin e1) | Trials (13,14-dihydroprostaglandin e1) | Recent Studies (post-2010) (13,14-dihydroprostaglandin e1) | Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) |
|---|---|---|---|---|---|
| 27 | 2 | 3 | 9,156 | 187 | 552 |
| Protein | Taxonomy | 13,14-dihydroprostaglandin e1 (IC50) | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) |
|---|---|---|---|
| Platelet-activating factor receptor | Homo sapiens (human) | 0.0003 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braun, M; Bruch, L; Ney, P; Schrör, K; Szymanski, C | 1 |
1 other study(ies) available for 13,14-dihydroprostaglandin e1 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Antiplatelet, antineutrophil and vasodilating properties of 13,14-dihydro-PGE1 (PGE0)--an in vivo metabolite of PGE1 in man.
Topics: Alprostadil; Animals; Blood Platelets; Glucuronidase; Humans; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Rabbits; Superoxides; Vasodilation | 1991 |